Summit Global Investments Bio Techne Corp Transaction History

Summit Global Investments

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 16, 2019	SELL	$188.72 - $215.43 $452,739 - $516,816	-2,399 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$136.09 - $200.44 $13,609 - $20,044	100 Added 4.35%	2,399 $476,000
Q4 2018 Feb 08, 2019	SELL	$132.75 - $203.8 $6.08 Million - $9.34 Million	-45,825 Reduced 95.22%	2,299 $333,000
Q3 2018 Nov 15, 2018	SELL	$147.44 - $204.11 $5,602 - $7,756	-38 Reduced 0.08%	48,124 $9.82 Million
Q2 2018 Aug 10, 2018	BUY	$144.9 - $165.58 $6.98 Million - $7.97 Million	48,162 New	48,162 $7.13 Million

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.87B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

Stay updated on Summit Global Investments with notifications on news.